Redmile Group, LLC significantly increased its stake in Scholar Rock Holding Corporation, buying 1,316,390 shares worth an estimated $49.37 million. This investment boosts Redmile Group’s position to 16.94% of its reportable assets under management. Scholar Rock’s shares have climbed 25.7% over the past year, indicating investor confidence ahead of a planned Biologics License Application resubmission for apitegromab.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26%
Redmile Group, LLC significantly increased its stake in Scholar Rock Holding Corporation, buying 1,316,390 shares worth an estimated $49.37 million. This investment boosts Redmile Group’s position to 16.94% of its reportable assets under management. Scholar Rock’s shares have climbed 25.7% over the past year, indicating investor confidence ahead of a planned Biologics License Application resubmission for apitegromab.